Pooled CRISPRi screening reveals fungal-specific vulnerabilities across environments and genetic backgrounds
Lauren F. WensingiD, Philippe C DesprésiD, Desiree FrancisiD, Meea FogaliD, Anthony HendriksiD, Nicholas C GervaisiD, Clara FikryiD, Abdul-Rahman Adamu BukariiD, Aleeza C. GersteiniD, Christina A. CuomoiD, Rebecca S. ShapiroiD
Abstract
The rising rate of drug-resistant fungal infections and the emergence of fungal pathogens with intrinsic resistance phenotypes are a growing concern. The close evolutionary distance between mammals and fungi complicates the design of new antifungals and increases the chances of toxic off-target effects. As such, antifungal drug development usually focuses on fungal-specific proteins when considering potential new targets. Ideal drug targets should mediate essential cell processes and be highly sensitive to inhibition. Targeted gene repression can serve as a model for drug-mediated inhibition and for determining the dosage-sensitivity profile of genes of interest. In the fungal pathogen Candida albicans, classical approaches for gene repression can be labour-intensive and limited to one genetic background due to low throughput. Here, we adapt pooled CRISPRi screening in C. albicans for the first time and exploit this technique for large-scale functional genomic analysis. Through pooled CRISPRi screening, we test the repression sensitivity of over a hundred essential genes conserved in fungi but absent in humans, and successfully identify highly dosage-sensitive genes across multiple cell components and pathways. By extending our analysis to ten diverse environmental conditions, we show how the environment influences dosage-sensitivity profiles. Finally, we extend our experiments to two clinical drug-resistant C. albicans strain backgrounds and demonstrate that many of the fitness defects we observed are conserved in resistant clinical isolates. Together, our results highlight a set of genes that are highly dosage-sensitive across different genetic and environmental contexts, making them attractive targets for further investigation. By facilitating rapid, efficient large-scale functional genomics assays across diverse genetic backgrounds, CRISPRi pooled screening will open new frontiers in C. albicans biology.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CRISPR-activation reveals key resistance genes and vulnerabilities of copy number variants in Candida albicans
Pétra Vande Zande, Nicholas C Gervais, … Anna M. Selmecki·bioRxiv·Aug 9, 2026
- Establishing Design Principles for CRISPR-Cas Antifungals in Candida albicans
Christopher J. Cotter, Cong T. Trinh·bioRxiv·Aug 28, 2026
- Chromosome-scale CRISPR screening reveals secretory pathway genes as drivers of aneuploidy-mediated antifungal tolerance
Nicholas C Gervais, Lauren F. Wensing, … Rebecca S. Shapiro·bioRxiv·Jul 24, 2026
- Potency of CRISPR-Cas Antifungals Is Enhanced by Co-targeting DNA Repair and Growth Regulatory Machinery at the Genetic Level
B. J. Mendoza, X. Zheng, … C. Trinh·bioRxiv·Jul 11, 2023
- Development and applications of a CRISPR activation system for facile genetic overexpression in Candida albicans
N. C. Gervais, A. A. La Bella, … R. S. Shapiro·bioRxiv·Aug 15, 2022
- CRISPR-GRIT: Guide-RNAs with Integrated Repair Templates Enable Precise Multiplexed Genome Editing in the Diploid Fungal Pathogen Candida albicans
Christopher J. Cotter, Cong T. Trinh·The CRISPR JournalPeer-reviewed·Oct 22, 2024